ANDREASI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 352
EU - Europa 290
AS - Asia 37
SA - Sud America 8
Totale 687
Nazione #
US - Stati Uniti d'America 350
SE - Svezia 152
IT - Italia 87
CN - Cina 26
GB - Regno Unito 15
IE - Irlanda 10
FI - Finlandia 7
BR - Brasile 6
DE - Germania 6
FR - Francia 6
IN - India 6
CA - Canada 2
CH - Svizzera 2
CL - Cile 2
JP - Giappone 2
PL - Polonia 2
TW - Taiwan 2
BE - Belgio 1
HK - Hong Kong 1
NL - Olanda 1
PT - Portogallo 1
Totale 687
Città #
Ashburn 108
Milan 32
New York 32
Shanghai 26
Lawrence 25
Princeton 25
Washington 21
London 13
Dublin 10
Los Angeles 8
Helsinki 7
Rome 7
Pune 5
Seattle 5
Tabira 5
Borgosesia 3
Philadelphia 3
Portland 3
Banqiao 2
Bern 2
Council Bluffs 2
Cureggio 2
Delianuova 2
Krakow 2
Madone 2
Malosco 2
New Orleans 2
Nocera Inferiore 2
San Jose 2
Trieste 2
Bomporto 1
Brussels 1
Campodolcino 1
Capriolo 1
Cesano Maderno 1
Cosenza 1
Forio 1
Hanover 1
Houston 1
Lagoa Santa 1
Palermo 1
Pittsburgh 1
Pombal 1
Presezzo 1
San Francisco 1
Santa Clara 1
Seregno 1
Sesto San Giovanni 1
Toronto 1
Vimercate 1
Woodbridge 1
Totale 383
Nome #
ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS 61
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 28
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 26
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 25
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 21
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 21
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 20
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 19
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 19
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 19
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 18
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 17
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 17
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 16
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 16
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 15
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) 15
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 15
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 15
Prognostic role of examined and positive lymph nodes after distal pancreatectomy for non-functioning neuroendocrine neoplasms 15
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 14
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 14
Update on gastroenteropancreatic neuroendocrine tumors 14
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 14
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 14
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 13
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 13
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 13
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 13
Local treatment for focal progression in metastatic neuroendocrine tumors 13
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 13
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 12
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 12
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms 12
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 11
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 10
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 10
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 10
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 10
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 9
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 9
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 9
New Surgical Strategies 8
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) 8
Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach 6
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 6
Non functional pancreatic neuroendocrine tumors 6
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 5
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors 5
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 5
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 4
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 4
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis 3
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 3
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 2
Totale 745
Categoria #
all - tutte 7.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/202121 0 0 0 1 0 17 2 0 1 0 0 0
2021/202230 0 1 1 6 4 2 10 0 0 2 1 3
2022/2023290 57 48 22 19 9 43 25 28 17 6 8 8
2023/2024403 18 25 69 53 61 108 6 47 4 12 0 0
Totale 745